Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach

BACKGROUND: Maintenance of the blind-to-treatment allocation is one of the most important means of avoiding bias in randomised controlled clinical trials. Commonly used methodologies to determine whether patients have become unblinded to treatment allocation are imperfect. This may be of particular...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Stephen, Duncombe, Paul, Altman, Douglas G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487910/
https://www.ncbi.nlm.nih.gov/pubmed/23046749
http://dx.doi.org/10.1186/1745-6215-13-189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487910/
https://www.ncbi.nlm.nih.gov/pubmed/23046749
http://dx.doi.org/10.1186/1745-6215-13-189

Ejemplares similares